Selected research
Industry Research
Comparator Drug and Ancillary Materials Sourcing Industry Research Report 2026
Market perspective
The global Comparator Drug and Ancillary Materials Sourcing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Comparator Drug and Ancillary Materials Sourcing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Comparator Drug and Ancillary Materials Sourcing is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Comparator Drug and Ancillary Materials Sourcing is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Comparator Drug and Ancillary Materials Sourcing include Alliance Pharm, Almac Group, Catalent, Cencora, ClientPharma, Clinical Services International (CSI), Clinigen, Globyz Pharma and Inceptua, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Comparator Drug and Ancillary Materials Sourcing market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Comparator Drug and Ancillary Materials Sourcing Market by Company
Alliance Pharm
Almac Group
Catalent
Cencora
ClientPharma
Clinical Services International (CSI)
Clinigen
Globyz Pharma
Inceptua
Mckesson Corporation
Myonex
NewLife Medicals
Oximio
Sharp Services, LLC
Wuxi New Drug Development
Thermo Fisher Scientific
Comparator Drug and Ancillary Materials Sourcing Segment by Type
Local Sourcing
Central Sourcing
Others
Comparator Drug and Ancillary Materials Sourcing Segment by Application
Drug Producers/Manufacturers
Academic and Research Institute
CMO
Others
Comparator Drug and Ancillary Materials Sourcing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Comparator Drug and Ancillary Materials Sourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Comparator Drug and Ancillary Materials Sourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Comparator Drug and Ancillary Materials Sourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Comparator Drug and Ancillary Materials Sourcing manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Comparator Drug and Ancillary Materials Sourcing by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Comparator Drug and Ancillary Materials Sourcing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Comparator Drug and Ancillary Materials Sourcing Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Comparator Drug and Ancillary Materials Sourcing Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Comparator Drug and Ancillary Materials Sourcing Revenue of Manufacturers (2021-2026)
Table 9. Global Comparator Drug and Ancillary Materials Sourcing Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Comparator Drug and Ancillary Materials Sourcing Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Comparator Drug and Ancillary Materials Sourcing Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Comparator Drug and Ancillary Materials Sourcing, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Comparator Drug and Ancillary Materials Sourcing, Product Type & Application
Table 14. Global Comparator Drug and Ancillary Materials Sourcing Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Comparator Drug and Ancillary Materials Sourcing by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Alliance Pharm Company Information
Table 19. Alliance Pharm Business Overview
Table 20. Alliance Pharm Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Alliance Pharm Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 22. Alliance Pharm Recent Developments
Table 23. Almac Group Company Information
Table 24. Almac Group Business Overview
Table 25. Almac Group Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Almac Group Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 27. Almac Group Recent Developments
Table 28. Catalent Company Information
Table 29. Catalent Business Overview
Table 30. Catalent Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Catalent Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 32. Catalent Recent Developments
Table 33. Cencora Company Information
Table 34. Cencora Business Overview
Table 35. Cencora Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Cencora Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 37. Cencora Recent Developments
Table 38. ClientPharma Company Information
Table 39. ClientPharma Business Overview
Table 40. ClientPharma Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. ClientPharma Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 42. ClientPharma Recent Developments
Table 43. Clinical Services International (CSI) Company Information
Table 44. Clinical Services International (CSI) Business Overview
Table 45. Clinical Services International (CSI) Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Clinical Services International (CSI) Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 47. Clinical Services International (CSI) Recent Developments
Table 48. Clinigen Company Information
Table 49. Clinigen Business Overview
Table 50. Clinigen Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Clinigen Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 52. Clinigen Recent Developments
Table 53. Globyz Pharma Company Information
Table 54. Globyz Pharma Business Overview
Table 55. Globyz Pharma Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Globyz Pharma Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 57. Globyz Pharma Recent Developments
Table 58. Inceptua Company Information
Table 59. Inceptua Business Overview
Table 60. Inceptua Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Inceptua Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 62. Inceptua Recent Developments
Table 63. Mckesson Corporation Company Information
Table 64. Mckesson Corporation Business Overview
Table 65. Mckesson Corporation Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Mckesson Corporation Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 67. Mckesson Corporation Recent Developments
Table 68. Myonex Company Information
Table 69. Myonex Business Overview
Table 70. Myonex Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Myonex Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 72. Myonex Recent Developments
Table 73. NewLife Medicals Company Information
Table 74. NewLife Medicals Business Overview
Table 75. NewLife Medicals Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. NewLife Medicals Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 77. NewLife Medicals Recent Developments
Table 78. Oximio Company Information
Table 79. Oximio Business Overview
Table 80. Oximio Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Oximio Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 82. Oximio Recent Developments
Table 83. Sharp Services, LLC Company Information
Table 84. Sharp Services, LLC Business Overview
Table 85. Sharp Services, LLC Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Sharp Services, LLC Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 87. Sharp Services, LLC Recent Developments
Table 88. Wuxi New Drug Development Company Information
Table 89. Wuxi New Drug Development Business Overview
Table 90. Wuxi New Drug Development Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Wuxi New Drug Development Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 92. Wuxi New Drug Development Recent Developments
Table 93. Thermo Fisher Scientific Company Information
Table 94. Thermo Fisher Scientific Business Overview
Table 95. Thermo Fisher Scientific Comparator Drug and Ancillary Materials Sourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Thermo Fisher Scientific Comparator Drug and Ancillary Materials Sourcing Product Portfolio
Table 97. Thermo Fisher Scientific Recent Developments
Table 98. Global Comparator Drug and Ancillary Materials Sourcing Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 99. Global Comparator Drug and Ancillary Materials Sourcing Sales by Region (2021-2026) & (k units)
Table 100. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Region (2021-2026)
Table 101. Global Comparator Drug and Ancillary Materials Sourcing Sales by Region (2027-2032) & (k units)
Table 102. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Region (2027-2032)
Table 103. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region (2021-2026) & (US$ Million)
Table 104. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Region (2021-2026)
Table 105. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region (2027-2032) & (US$ Million)
Table 106. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Region (2027-2032)
Table 107. North America Comparator Drug and Ancillary Materials Sourcing Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. North America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 109. North America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 110. North America Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2026) & (US$ Million)
Table 111. North America Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2027-2032) & (US$ Million)
Table 112. Europe Comparator Drug and Ancillary Materials Sourcing Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. Europe Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 114. Europe Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 115. Europe Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2026) & (US$ Million)
Table 116. Europe Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2027-2032) & (US$ Million)
Table 117. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 119. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 120. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2026) & (US$ Million)
Table 121. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2027-2032) & (US$ Million)
Table 122. South America Comparator Drug and Ancillary Materials Sourcing Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. South America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 124. South America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 125. South America Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2026) & (US$ Million)
Table 126. South America Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2027-2032) & (US$ Million)
Table 127. Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2026) & (k units)
Table 129. Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales by Country (2027-2032) & (k units)
Table 130. Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2026) & (US$ Million)
Table 131. Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2027-2032) & (US$ Million)
Table 132. Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2021-2026) & (k units)
Table 133. Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2027-2032) & (k units)
Table 134. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Type (2021-2026)
Table 135. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Type (2027-2032)
Table 136. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type (2021-2026) & (US$ Million)
Table 137. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type (2027-2032) & (US$ Million)
Table 138. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Type (2021-2026)
Table 139. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Type (2027-2032)
Table 140. Global Comparator Drug and Ancillary Materials Sourcing Price by Type (2021-2026) & (USD/unit)
Table 141. Global Comparator Drug and Ancillary Materials Sourcing Price by Type (2027-2032) & (USD/unit)
Table 142. Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2021-2026) & (k units)
Table 143. Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2027-2032) & (k units)
Table 144. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Application (2021-2026)
Table 145. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Application (2027-2032)
Table 146. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application (2021-2026) & (US$ Million)
Table 147. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application (2027-2032) & (US$ Million)
Table 148. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Application (2021-2026)
Table 149. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Application (2027-2032)
Table 150. Global Comparator Drug and Ancillary Materials Sourcing Price by Application (2021-2026) & (USD/unit)
Table 151. Global Comparator Drug and Ancillary Materials Sourcing Price by Application (2027-2032) & (USD/unit)
Table 152. Key Raw Materials
Table 153. Raw Materials Key Suppliers
Table 154. Comparator Drug and Ancillary Materials Sourcing Distributors List
Table 155. Comparator Drug and Ancillary Materials Sourcing Customers List
Table 156. Comparator Drug and Ancillary Materials Sourcing Industry Trends
Table 157. Comparator Drug and Ancillary Materials Sourcing Industry Drivers
Table 158. Comparator Drug and Ancillary Materials Sourcing Industry Restraints
Table 159. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Comparator Drug and Ancillary Materials Sourcing Product Image
Figure 5. Global Comparator Drug and Ancillary Materials Sourcing Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Comparator Drug and Ancillary Materials Sourcing Market Size (2021-2032) & (US$ Million)
Figure 7. Global Comparator Drug and Ancillary Materials Sourcing Sales (2021-2032) & (k units)
Figure 8. Global Comparator Drug and Ancillary Materials Sourcing Average Price (USD/unit) & (2021-2032)
Figure 9. Local Sourcing Product Image
Figure 10. Central Sourcing Product Image
Figure 11. Others Product Image
Figure 12. Drug Producers/Manufacturers Product Image
Figure 13. Academic and Research Institute Product Image
Figure 14. CMO Product Image
Figure 15. Others Product Image
Figure 16. Global Comparator Drug and Ancillary Materials Sourcing Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Comparator Drug and Ancillary Materials Sourcing, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Comparator Drug and Ancillary Materials Sourcing Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Comparator Drug and Ancillary Materials Sourcing Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Comparator Drug and Ancillary Materials Sourcing Sales by Region in 2025
Figure 22. Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region in 2025
Figure 23. North America Comparator Drug and Ancillary Materials Sourcing Market Size by Country in 2025
Figure 24. North America Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 25. North America Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Country (2021-2032)
Figure 26. United States Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Mexico Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Comparator Drug and Ancillary Materials Sourcing Market Size by Country in 2025
Figure 30. Europe Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 31. Europe Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Country (2021-2032)
Figure 32. Germany Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Russia Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Spain Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Switzerland Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Sweden Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Poland Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Market Size by Country in 2025
Figure 43. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 44. Asia Pacific Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Country (2021-2032)
Figure 45. China Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Japan Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South Korea Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. India Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Australia Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Taiwan Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. South America Comparator Drug and Ancillary Materials Sourcing Market Size by Country in 2025
Figure 54. South America Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 55. South America Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Country (2021-2032)
Figure 56. Brazil Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Argentina Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Chile Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Market Size by Country in 2025
Figure 60. Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Comparator Drug and Ancillary Materials Sourcing Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Type (2021-2032)
Figure 68. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Type (2021-2032)
Figure 69. Global Comparator Drug and Ancillary Materials Sourcing Price (USD/unit) by Type (2021-2032)
Figure 70. Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Application (2021-2032)
Figure 71. Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Application (2021-2032)
Figure 72. Global Comparator Drug and Ancillary Materials Sourcing Price (USD/unit) by Application (2021-2032)
Figure 73. Comparator Drug and Ancillary Materials Sourcing Value Chain
Figure 74. Comparator Drug and Ancillary Materials Sourcing Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Comparator Drug and Ancillary Materials Sourcing Industry Opportunities and Challenges
Scope & coverage.
Types
- Local Sourcing
- Central Sourcing
- Others
Applications
- Drug Producers/Manufacturers
- Academic and Research Institute
- CMO
- Others
Companies covered
- Alliance Pharm
- Almac Group
- Catalent
- Cencora
- ClientPharma
- Clinical Services International (CSI)
- Clinigen
- Globyz Pharma
- Inceptua
- Mckesson Corporation
- Myonex
- NewLife Medicals
- Oximio
- Sharp Services, LLC
- Wuxi New Drug Development
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Comparator Drug and Ancillary Materials Sourcing Market Size (2021-2032)
- 2.2.2 Global Comparator Drug and Ancillary Materials Sourcing Sales (2021-2032)
- 2.2.3 Global Comparator Drug and Ancillary Materials Sourcing Market Average Price (2021-2032)
- 2.3 Comparator Drug and Ancillary Materials Sourcing by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Local Sourcing
- 2.3.3 Central Sourcing
- 2.3.4 Others
- 2.4 Comparator Drug and Ancillary Materials Sourcing by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Drug Producers/Manufacturers
- 2.4.3 Academic and Research Institute
- 2.4.4 CMO
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Comparator Drug and Ancillary Materials Sourcing Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Comparator Drug and Ancillary Materials Sourcing Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Comparator Drug and Ancillary Materials Sourcing Revenue of Manufacturers (2021-2026)
- 3.4 Global Comparator Drug and Ancillary Materials Sourcing Average Price by Manufacturers (2021-2026)
- 3.5 Global Comparator Drug and Ancillary Materials Sourcing Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Comparator Drug and Ancillary Materials Sourcing, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Comparator Drug and Ancillary Materials Sourcing, Product Type & Application
- 3.8 Global Manufacturers of Comparator Drug and Ancillary Materials Sourcing, Established Date
- 3.9 Global Comparator Drug and Ancillary Materials Sourcing Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alliance Pharm
- 4.1.1 Alliance Pharm Company Information
- 4.1.2 Alliance Pharm Business Overview
- 4.1.3 Alliance Pharm Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alliance Pharm Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.1.5 Alliance Pharm Recent Developments
- 4.2 Almac Group
- 4.2.1 Almac Group Company Information
- 4.2.2 Almac Group Business Overview
- 4.2.3 Almac Group Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Almac Group Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.2.5 Almac Group Recent Developments
- 4.3 Catalent
- 4.3.1 Catalent Company Information
- 4.3.2 Catalent Business Overview
- 4.3.3 Catalent Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Catalent Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.3.5 Catalent Recent Developments
- 4.4 Cencora
- 4.4.1 Cencora Company Information
- 4.4.2 Cencora Business Overview
- 4.4.3 Cencora Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cencora Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.4.5 Cencora Recent Developments
- 4.5 ClientPharma
- 4.5.1 ClientPharma Company Information
- 4.5.2 ClientPharma Business Overview
- 4.5.3 ClientPharma Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 ClientPharma Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.5.5 ClientPharma Recent Developments
- 4.6 Clinical Services International (CSI)
- 4.6.1 Clinical Services International (CSI) Company Information
- 4.6.2 Clinical Services International (CSI) Business Overview
- 4.6.3 Clinical Services International (CSI) Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Clinical Services International (CSI) Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.6.5 Clinical Services International (CSI) Recent Developments
- 4.7 Clinigen
- 4.7.1 Clinigen Company Information
- 4.7.2 Clinigen Business Overview
- 4.7.3 Clinigen Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Clinigen Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.7.5 Clinigen Recent Developments
- 4.8 Globyz Pharma
- 4.8.1 Globyz Pharma Company Information
- 4.8.2 Globyz Pharma Business Overview
- 4.8.3 Globyz Pharma Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Globyz Pharma Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.8.5 Globyz Pharma Recent Developments
- 4.9 Inceptua
- 4.9.1 Inceptua Company Information
- 4.9.2 Inceptua Business Overview
- 4.9.3 Inceptua Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Inceptua Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.9.5 Inceptua Recent Developments
- 4.10 Mckesson Corporation
- 4.10.1 Mckesson Corporation Company Information
- 4.10.2 Mckesson Corporation Business Overview
- 4.10.3 Mckesson Corporation Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mckesson Corporation Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.10.5 Mckesson Corporation Recent Developments
- 4.11 Myonex
- 4.11.1 Myonex Company Information
- 4.11.2 Myonex Business Overview
- 4.11.3 Myonex Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Myonex Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.11.5 Myonex Recent Developments
- 4.12 NewLife Medicals
- 4.12.1 NewLife Medicals Company Information
- 4.12.2 NewLife Medicals Business Overview
- 4.12.3 NewLife Medicals Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 NewLife Medicals Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.12.5 NewLife Medicals Recent Developments
- 4.13 Oximio
- 4.13.1 Oximio Company Information
- 4.13.2 Oximio Business Overview
- 4.13.3 Oximio Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Oximio Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.13.5 Oximio Recent Developments
- 4.14 Sharp Services, LLC
- 4.14.1 Sharp Services, LLC Company Information
- 4.14.2 Sharp Services, LLC Business Overview
- 4.14.3 Sharp Services, LLC Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Sharp Services, LLC Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.14.5 Sharp Services, LLC Recent Developments
- 4.15 Wuxi New Drug Development
- 4.15.1 Wuxi New Drug Development Company Information
- 4.15.2 Wuxi New Drug Development Business Overview
- 4.15.3 Wuxi New Drug Development Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Wuxi New Drug Development Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.15.5 Wuxi New Drug Development Recent Developments
- 4.16 Thermo Fisher Scientific
- 4.16.1 Thermo Fisher Scientific Company Information
- 4.16.2 Thermo Fisher Scientific Business Overview
- 4.16.3 Thermo Fisher Scientific Comparator Drug and Ancillary Materials Sourcing Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Thermo Fisher Scientific Comparator Drug and Ancillary Materials Sourcing Product Portfolio
- 4.16.5 Thermo Fisher Scientific Recent Developments
5 Global Comparator Drug and Ancillary Materials Sourcing Market Scenario by Region
- 5.1 Global Comparator Drug and Ancillary Materials Sourcing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Comparator Drug and Ancillary Materials Sourcing Sales by Region: 2021-2032
- 5.2.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Region: 2021-2026
- 5.2.2 Global Comparator Drug and Ancillary Materials Sourcing Sales by Region: 2027-2032
- 5.3 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region: 2021-2032
- 5.3.1 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region: 2021-2026
- 5.3.2 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Region: 2027-2032
- 5.4 North America Comparator Drug and Ancillary Materials Sourcing Market Facts & Figures by Country
- 5.4.1 North America Comparator Drug and Ancillary Materials Sourcing Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 5.4.3 North America Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Comparator Drug and Ancillary Materials Sourcing Market Facts & Figures by Country
- 5.5.1 Europe Comparator Drug and Ancillary Materials Sourcing Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 5.5.3 Europe Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Comparator Drug and Ancillary Materials Sourcing Market Facts & Figures by Country
- 5.6.1 Asia Pacific Comparator Drug and Ancillary Materials Sourcing Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Comparator Drug and Ancillary Materials Sourcing Market Facts & Figures by Country
- 5.7.1 South America Comparator Drug and Ancillary Materials Sourcing Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 5.7.3 South America Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Comparator Drug and Ancillary Materials Sourcing Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2021-2032)
- 6.1.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Type (2021-2032)
- 6.2 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Type (2021-2032)
- 6.2.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Type (2021-2032)
- 6.3 Global Comparator Drug and Ancillary Materials Sourcing Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2021-2032)
- 7.1.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Comparator Drug and Ancillary Materials Sourcing Sales Market Share by Application (2021-2032)
- 7.2 Global Comparator Drug and Ancillary Materials Sourcing Revenue by Application (2021-2032)
- 7.2.1 Global Comparator Drug and Ancillary Materials Sourcing Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Comparator Drug and Ancillary Materials Sourcing Revenue Market Share by Application (2021-2032)
- 7.3 Global Comparator Drug and Ancillary Materials Sourcing Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Comparator Drug and Ancillary Materials Sourcing Value Chain Analysis
- 8.1.1 Comparator Drug and Ancillary Materials Sourcing Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Comparator Drug and Ancillary Materials Sourcing Production Mode & Process
- 8.2 Comparator Drug and Ancillary Materials Sourcing Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Comparator Drug and Ancillary Materials Sourcing Distributors
- 8.2.3 Comparator Drug and Ancillary Materials Sourcing Customers
9 Global Comparator Drug and Ancillary Materials Sourcing Analyzing Market Dynamics
- 9.1 Comparator Drug and Ancillary Materials Sourcing Industry Trends
- 9.2 Comparator Drug and Ancillary Materials Sourcing Industry Drivers
- 9.3 Comparator Drug and Ancillary Materials Sourcing Industry Opportunities and Challenges
- 9.4 Comparator Drug and Ancillary Materials Sourcing Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst